92 related articles for article (PubMed ID: 34356777)
1. Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19.
Azam F
Antibiotics (Basel); 2021 Jul; 10(7):. PubMed ID: 34356777
[TBL] [Abstract][Full Text] [Related]
2. Targeting SARS-CoV-2 main protease by teicoplanin: A mechanistic insight by docking, MM/GBSA and molecular dynamics simulation.
Azam F; Eid EEM; Almutairi A
J Mol Struct; 2021 Dec; 1246():131124. PubMed ID: 34305175
[TBL] [Abstract][Full Text] [Related]
3. An
Azam F; Taban IM; Eid EEM; Iqbal M; Alam O; Khan S; Mahmood D; Anwar MJ; Khalilullah H; Khan MU
J Biomol Struct Dyn; 2022 Apr; 40(6):2851-2864. PubMed ID: 33131430
[TBL] [Abstract][Full Text] [Related]
4. Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD.
Chauhan A; Avti P; Shekhar N; Prajapat M; Sarma P; Bhattacharyya A; Kumar S; Kaur H; Prakash A; Medhi B
Comput Biol Med; 2021 Jul; 134():104495. PubMed ID: 34022485
[TBL] [Abstract][Full Text] [Related]
5. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
6. Natural compounds from
Kar P; Sharma NR; Singh B; Sen A; Roy A
J Biomol Struct Dyn; 2021 Aug; 39(13):4774-4785. PubMed ID: 32552595
[TBL] [Abstract][Full Text] [Related]
7. Insight into the LFA-1/SARS-CoV-2 Orf7a Complex by Protein-Protein Docking, Molecular Dynamics, and MM-GBSA Calculations.
Ongaro A; Oselladore E; Memo M; Ribaudo G; Gianoncelli A
J Chem Inf Model; 2021 Jun; 61(6):2780-2787. PubMed ID: 34043356
[TBL] [Abstract][Full Text] [Related]
8. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors.
Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF
Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388
[TBL] [Abstract][Full Text] [Related]
9. In silico prediction of potential inhibitors for the main protease of SARS-CoV-2 using molecular docking and dynamics simulation based drug-repurposing.
Kumar Y; Singh H; Patel CN
J Infect Public Health; 2020 Sep; 13(9):1210-1223. PubMed ID: 32561274
[TBL] [Abstract][Full Text] [Related]
10. Computational screening of dual inhibitors from FDA approved antiviral drugs on SARS-CoV-2 spike protein and the main protease using molecular docking approach.
Sabarimurugan S; Purushothaman I; Swaminathan R; Dharmarajan A; Warrier S; Kothandan S
Acta Virol; 2021; 65(2):160-172. PubMed ID: 34130467
[TBL] [Abstract][Full Text] [Related]
11. Identifying novel inhibitor of quorum sensing transcriptional regulator (SdiA) of
Ahmed MZ; Muteeb G; Khan S; Alqahtani AS; Somvanshi P; Alqahtani MS; Ameta KL; Haque S
J Biomol Struct Dyn; 2021 Jul; 39(10):3594-3604. PubMed ID: 32401149
[TBL] [Abstract][Full Text] [Related]
12. Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic.
Muteeb G; Alshoaibi A; Aatif M; Rehman MT; Qayyum MZ
Appl Biol Chem; 2020; 63(1):79. PubMed ID: 33251389
[TBL] [Abstract][Full Text] [Related]
13. Stilbene-based natural compounds as promising drug candidates against COVID-19.
Wahedi HM; Ahmad S; Abbasi SW
J Biomol Struct Dyn; 2021 Jun; 39(9):3225-3234. PubMed ID: 32345140
[TBL] [Abstract][Full Text] [Related]
14. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
[TBL] [Abstract][Full Text] [Related]
15. Integrating Ligand and Target-Driven Based Virtual Screening Approaches With
Tutumlu G; Dogan B; Avsar T; Orhan MD; Calis S; Durdagi S
Front Chem; 2020; 8():167. PubMed ID: 32328476
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13.
Cruz JN; Costa JFS; Khayat AS; Kuca K; Barros CAL; Neto AMJC
J Biomol Struct Dyn; 2019 Apr; 37(6):1616-1627. PubMed ID: 29633908
[TBL] [Abstract][Full Text] [Related]
17. In silico identification of potential inhibitors of key SARS-CoV-2 3CL hydrolase (Mpro) via molecular docking, MMGBSA predictive binding energy calculations, and molecular dynamics simulation.
Choudhary MI; Shaikh M; Tul-Wahab A; Ur-Rahman A
PLoS One; 2020; 15(7):e0235030. PubMed ID: 32706783
[TBL] [Abstract][Full Text] [Related]
18. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
Wakchaure PD; Ghosh S; Ganguly B
J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
[TBL] [Abstract][Full Text] [Related]
19. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations.
Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA
Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993
[TBL] [Abstract][Full Text] [Related]
20. Promising inhibitors of main protease of novel corona virus to prevent the spread of COVID-19 using docking and molecular dynamics simulation.
Kumar D; Kumari K; Vishvakarma VK; Jayaraj A; Kumar D; Ramappa VK; Patel R; Kumar V; Dass SK; Chandra R; Singh P
J Biomol Struct Dyn; 2021 Aug; 39(13):4671-4685. PubMed ID: 32567995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
